Otofarma SpAMIL:OTO -0.71%16 PB Ratio is 3.17 as of Jun. 29, 2026. GuruFocus rates MIL:OTO with a GF Score™ of 16/100. The stock has 1 warning sign investors should review. Among 786 Medical Devices & Instruments companies, Otofarma SpA ranks worse than 66.54% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-29), Otofarma SpA's share price is €2.80. Otofarma SpA's Book Value per Share for the quarter that ended in Dec. 2024 was €0.88. Hence, Otofarma SpA's PB Ratio of today is 3.17.
The historical rank and industry rank for Otofarma SpA's PB Ratio or its related term are showing as below:
MIL:OTO'
s PB Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 3.17
Current: 3.17
During the past 2 years, Otofarma SpA's highest PB Ratio was 3.17. The lowest was 0.00. And the median was 0.00.
MIL:OTO's PB Ratio is ranked worse than 66.54% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 2.015
vs MIL:OTO: 3.17
During the past 12 months, Otofarma SpA's average Book Value Per Share Growth Rate was 55.60% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Otofarma SpA PB Ratio Related Terms
Otofarma SpA PB Ratio Historical Data
* Premium members only.
The historical data trend for Otofarma SpA's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Otofarma SpA PB Ratio Chart
Otofarma SpA Annual Data
Trend
Dec23
Dec24
PB Ratio
0.00
0.00
Otofarma SpA Semi-Annual Data
Dec23
Dec24
PB Ratio
0.00
0.00
MIL:OTO vs ABT, SYK, MDT: PB Ratio Comparison
For the Medical Devices subindustry, Otofarma SpA's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Otofarma SpA PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Otofarma SpA's PB Ratio distribution charts can be found below:
* The bar in red indicates where Otofarma SpA's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Otofarma SpA's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Otofarma SpA (MIL:OTO) has a PB Ratio of 3.17 as of Jun. 29, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Otofarma SpA and its competitors. According to the industry distribution chart, Otofarma SpA ranks #523 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 66.5%.
Is Otofarma SpA's PB Ratio too high?
Otofarma SpA's current PB Ratio is 3.17. The Medical Devices & Instruments industry median PB Ratio is 2.02. Otofarma SpA's value of 3.17 is 57.3% above this industry median. Based on the distribution chart, Otofarma SpA ranks #523 out of 786 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Otofarma SpA has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Otofarma SpA's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Otofarma SpA ranks #523 out of 786 companies for PB Ratio. This places Otofarma SpA in the lower half of its industry. The industry median PB Ratio is 2.02. Otofarma SpA's value of 3.17 is 57.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.02, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Otofarma SpA's current PB Ratio of 3.17 is 57.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Otofarma SpA and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Otofarma SpA's current PB Ratio is 3.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otofarma SpA stock overvalued right now?
Otofarma SpA (MIL:OTO) has a current PB Ratio of 3.17. The current PB Ratio is 3.17 and 57.3% above the Medical Devices & Instruments industry median of 2.02. Otofarma SpA's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Otofarma SpA (MIL:OTO), the current PB Ratio is 3.17 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Otofarma SpA is engaged in the construction and production of hearing aids, is constantly growing in the audiological field to provide adequate responses to every type of hearing aid need to its customers who require the possible personalized application of custom-made hearing aids. It provides otoacoustic medical devices and TELEMEDICINE services exclusively in affiliated pharmacies, possessing a portfolio of Instrumental IT patents.
16GF Score
Get the complete analysis for MIL:OTO
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:OTO has been successfully added to your 